Akanda SG&A Expense (Quarterly) Analysis

Akanda Corp. (AKAN)

0.9487 +0.02 (+2.01%) USD | NASDAQ | Feb 23, 10:15

View SG&A Expense (Quarterly) for AKAN.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View SG&A Expense (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View SG&A Expense (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View SG&A Expense (Quarterly) Benchmarks

Start Trial

NovoCure Ltd.	104.47M
LivaNova Plc	138.52M
Alterola Biotech, Inc.	--
Kiniksa Pharmaceuticals International Plc	49.10M
Plus Therapeutics, Inc.	3.443M